Metraipolis › archive › dc_e12d237a70e6

[Efficacy and safety analysis of avapritinib in children with RUNX1::RUNX1T1 positive-acute myeloid leukemia with KIT mutations] — Europe PMC PMID:42161658

Source
Europe PMC (chi)
Original
https://europepmc.org/article/MED/42161658
DOI
10.3760/cma.j.cn121090-20251027-00482
License (as archived)
solo-consultazione
Archived
2026-11-03T14:04:48.241Z
SHA-256 of the archived text
aa946ff3ee990576d00459f2db4e4327afa6c99d4f86003feed873105dbbaa5b
Stable URL of this page
https://metraipolis.com/documento/dc_e12d237a70e6

How to cite

[Efficacy and safety analysis of avapritinib in children with RUNX1::RUNX1T1 positive-acute myeloid leukemia with KIT mutations] — Europe PMC PMID:42161658 — Europe PMC (chi), https://europepmc.org/article/MED/42161658 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e12d237a70e6 (Metraipolis archive dc_e12d237a70e6, sha256 aa946ff3ee990576d00459f2db4e4327afa6c99d4f86003feed873105dbbaa5b)
BibTeX
@misc{dce12d237a70e6,
  title = {[Efficacy and safety analysis of avapritinib in children with RUNX1::RUNX1T1 positive-acute myeloid leukemia with KIT mutations] — Europe PMC PMID:42161658},
  howpublished = {Europe PMC (chi)},
  url = {https://europepmc.org/article/MED/42161658},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e12d237a70e6; sha256 aa946ff3ee990576d00459f2db4e4327afa6c99d4f86003feed873105dbbaa5b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42161658. Agents can read the archived copy with the MCP tool read_document.